AAA

ASCENTAGE PHARMA GROUP

No trades
See on Supercharts
Next report date
Report period
H1 2024
EPS estimate
Revenue estimate
Market capitalization
‪676.15 M‬USD
−0.46USD
‪−130.95 M‬USD
‪31.40 M‬USD
‪212.77 M‬
Beta (1Y)
1.34

About ASCENTAGE PHARMA GROUP INTL

CEO
Da Jan Yang
Headquarters
Suzhou
Employees (FY)
583
Founded
2009
FIGI
BBG00YQ18G19
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company, which engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. It operates through United States and Mainland China geographical segments. The company was founded by Dajun Yang and Ming Guo in May 2009 and is headquartered in Suzhou, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ASPHF is 2.50 USD — it has decreased by 3.85% in the past 24 hours. Watch ASCENTAGE PHARMA GROUP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange ASCENTAGE PHARMA GROUP stocks are traded under the ticker ASPHF.
ASCENTAGE PHARMA GROUP is going to release the next earnings report on Aug 20, 2024. Keep track of upcoming events with our Earnings Calendar.
ASPHF stock is 4.00% volatile and has beta coefficient of 1.34. Track ASCENTAGE PHARMA GROUP stock price on the chart and check out the list of the most volatile stocks — is ASCENTAGE PHARMA GROUP there?
Yes, you can track ASCENTAGE PHARMA GROUP financials in yearly and quarterly reports right on TradingView.
ASPHF net income for the last quarter is ‪−72.38 M‬ USD, while the quarter before that showed ‪−58.05 M‬ USD of net income which accounts for −24.68% change. Track more ASCENTAGE PHARMA GROUP financial stats to get the full picture.
Today ASCENTAGE PHARMA GROUP has the market capitalization of ‪682.96 M‬, it has decreased by 0.02% over the last week.
No, ASPHF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, ASPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ASCENTAGE PHARMA GROUP stock right from TradingView charts — choose your broker and connect to your account.
ASPHF reached its all-time high on May 21, 2021 with the price of 6.10 USD, and its all-time low was 2.35 USD and was reached on Feb 13, 2024. View more price dynamics on ASPHF chart.
See other stocks reaching their highest and lowest prices.
As of May 4, 2024, the company has 583.00 employees. See our rating of the largest employees — is ASCENTAGE PHARMA GROUP on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ASCENTAGE PHARMA GROUP technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ASCENTAGE PHARMA GROUP stock shows the strong sell signal. See more of ASCENTAGE PHARMA GROUP technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ASCENTAGE PHARMA GROUP future price: according to them, ASPHF price has a max estimate of 2.94 USD and a min estimate of 2.94 USD. Watch ASPHF chart and read a more detailed ASCENTAGE PHARMA GROUP stock forecast: see what analysts think of ASCENTAGE PHARMA GROUP and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ASCENTAGE PHARMA GROUP EBITDA is ‪−114.78 M‬ USD, and current EBITDA margin is −367.00%. See more stats in ASCENTAGE PHARMA GROUP financial statements.